Pranlukast



Indications and Reactions:

Role Indications Reactions
Primary
Asthma 50.0%
Status Asthmaticus 50.0%
Blood Glucose Increased 100.0%
Secondary
Rheumatoid Arthritis 19.6%
Asthma 16.1%
Product Used For Unknown Indication 14.0%
Interstitial Lung Disease 9.8%
Nervous System Disorder 7.0%
Gastritis Prophylaxis 4.9%
Hypertension 4.9%
Hypercholesterolaemia 4.2%
Lumbar Spinal Stenosis 4.2%
Bronchitis 2.1%
Epilepsy 2.1%
Infantile Spasms 2.1%
Bronchitis Chronic 1.4%
Drug Use For Unknown Indication 1.4%
Pneumonia 1.4%
Productive Cough 1.4%
Sputum Retention 1.4%
Allergic Granulomatous Angiitis 0.7%
Allergy Prophylaxis 0.7%
Antiviral Treatment 0.7%
Interstitial Lung Disease 33.3%
Allergic Granulomatous Angiitis 8.3%
Asthma 8.3%
Leucine Aminopeptidase Increased 8.3%
Rhabdomyolysis 8.3%
Pneumonia 4.2%
Pregnancy 4.2%
Pyrexia 4.2%
Status Epilepticus 4.2%
Thirst 4.2%
Thrombocytopenia 4.2%
Ventricular Extrasystoles 4.2%
Weight Decreased 4.2%
Concomitant
Product Used For Unknown Indication 28.6%
Asthma 20.4%
Rheumatoid Arthritis 12.3%
Prophylaxis 9.6%
Drug Use For Unknown Indication 3.0%
Hypertension 2.8%
Glycogen Storage Disease Type Ii 2.5%
Premedication 2.3%
Adverse Drug Reaction 2.0%
Diabetes Mellitus 2.0%
Myelodysplastic Syndrome 2.0%
Antifungal Prophylaxis 1.7%
Nasopharyngitis 1.7%
Pruritus 1.7%
Aplastic Anaemia 1.3%
Emphysema 1.3%
Schizophrenia 1.3%
Anaemia 1.2%
Bone Marrow Conditioning Regimen 1.2%
Gastroenteritis 1.2%
Asthma 8.8%
Dyspnoea 7.5%
Rheumatoid Arthritis 7.5%
Thrombocytopenia 7.5%
Tubulointerstitial Nephritis 7.5%
White Blood Cell Count Increased 7.5%
Anaphylactoid Reaction 6.3%
Eosinophilic Pneumonia 6.3%
Vomiting 5.0%
White Blood Cell Count Decreased 5.0%
Cardio-respiratory Arrest 3.8%
Malignant Melanoma 3.8%
Nausea 3.8%
Rash 3.8%
Restlessness 3.8%
Cardiac Failure 2.5%
Completed Suicide 2.5%
Drug Dependence 2.5%
Gait Disturbance 2.5%
Heat Illness 2.5%
Interacting
Depression 100.0%
Serotonin Syndrome 100.0%